Drug price hearing focuses on off-patent spikes

Modern Healthcare: A Senate subcommittee has asked four drug companies to provide company records, research and marketing cost information to better understand how drugmakers set the prices of products they've recently acquired.

The U.S. Senate Special Committee on Aging, which on Wednesday will host its first hearing on the topic, hasn't yet said which, if any, of the companies complied with the request for records.

Read article